Related Experiment Video
Updated: Apr 2, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Clinical Interpretation of Modest Blood Pressure Changes After SGLT2 Inhibitor Initiation
Mehmet Alp Şahin1, Osman Karaarslan1, Mehmet Mustafa Yılmaz1
1Department of Cardiology, Hitit University Erol Olçok Education and Research Hospital, Corum, Turkey.
Sodium-glucose cotransporter-2 (SGLT2) inhibitors show modest blood pressure reduction in patients with diabetes. This real-world analysis highlights potential limitations in measurement and interpretation for SGLT2 inhibitor cardiovascular effect studies.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Sodium-glucose cotransporter-2 (SGLT2) inhibitors are used for diabetes management.
- These agents have shown modest blood pressure-lowering effects in patients with diabetes and cardiovascular disease.
- Real-world data on blood pressure changes following SGLT2 inhibitor initiation is valuable.
Related Concept Videos
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Hypertension I: Introduction
Antihypertensive Drugs: Action of Diuretics
